Lyfegen Secures additional CHF 5 Million in Series A Funding to Scale Its Drug Rebate Management Platform Globally
BASEL, Switzerland and BOSTON, Dec. 11, 2024 /PRNewswire/
Lyfegen, a global leader in Drug Rebate Management technology, today announced the successful close of its additional CHF 5 Million Series A Funding round. The round was led by TX Ventures, a leading European fintech investor, with additional participation from aMoon, a global health-tech venture capital firm, and other institutional investors. This Funding represents a significant milestone for Lyfegen, enabling the company to accelerate its global expansion and innovation efforts, with a focus on extending its reach beyond Europe into new markets worldwide. Addressing Rising Drug Costs with Intelligent Drug Pricing and Rebate SolutionsThe healthcare industry faces increasing challenges with rising Drug costs and the complexity of managing growing volumes of Rebate agreements.Leggi su Liberoquotidiano.it
Lyfegen, a global leader in Drug Rebate Management technology, today announced the successful close of its additional CHF 5 Million Series A Funding round. The round was led by TX Ventures, a leading European fintech investor, with additional participation from aMoon, a global health-tech venture capital firm, and other institutional investors. This Funding represents a significant milestone for Lyfegen, enabling the company to accelerate its global expansion and innovation efforts, with a focus on extending its reach beyond Europe into new markets worldwide. Addressing Rising Drug Costs with Intelligent Drug Pricing and Rebate SolutionsThe healthcare industry faces increasing challenges with rising Drug costs and the complexity of managing growing volumes of Rebate agreements.
Liberoquotidiano.it - Lyfegen Secures additional CHF 5 Million in Series A Funding to Scale Its Drug Rebate Management Platform Globally
- Lyfegen Secures additional CHF 5 Million in Series A Funding to Scale Its Drug Rebate Management Platform Globally
- Lyfegen Secures additional CHF 5 Million in Series A Funding to Scale Its Drug Rebate Management Platform Globally - Lyfegen, a global leader in drug rebate management technology, today announced the successful close of its additional CHF 5 million Series A funding round. The round was led by TX Ventures, a leading ... (adnkronos.com)
Via le auto dal terminal dei bus: controlli (e multe) con le telecamere arezzonotizie.it
Jazzin’up Christmas, il concerto di Natale con Lil Darling Quartet all'Osteria Rabezzana torinotoday.it
La cerniera, quella spinta gentile che può cambiare il nostro comportamento formiche.net
'Patto per la lettura' a Vicopisano pisatoday.it
La nave sotto sequestro da 300 giorni dove sopravvivono tre marinai triesteprima.it
Canta in un piano bar mentre è in malattia. La Cassazione, "il datore di lavoro non può licenziarlo" triesteprima.it
Reali di Spagna in visita in Italia, accolti da Mattarella e Meloni. Felipe: “Una visita speciale” sbircialanotizia.it
Jazzin’up Christmas, il concerto di Natale con Lil Darling Quartet all'Osteria Rabezzana torinotoday.it
La cerniera, quella spinta gentile che può cambiare il nostro comportamento formiche.net
'Patto per la lettura' a Vicopisano pisatoday.it
La nave sotto sequestro da 300 giorni dove sopravvivono tre marinai triesteprima.it
Canta in un piano bar mentre è in malattia. La Cassazione, "il datore di lavoro non può licenziarlo" triesteprima.it
Reali di Spagna in visita in Italia, accolti da Mattarella e Meloni. Felipe: “Una visita speciale” sbircialanotizia.it
Video Lyfegen Secures